1. Overview:
- Definition: Sleep apnoea is a sleep disorder characterized by repeated episodes of partial or complete upper airway obstruction during sleep, leading to disrupted sleep and intermittent hypoxia.
- Types:
- Obstructive Sleep Apnoea (OSA): Most common, due to airway obstruction.
- Central Sleep Apnoea (CSA): Caused by a failure of the brain to signal the muscles to breathe.
- Mixed Sleep Apnoea: Combination of obstructive and central features.
2. Epidemiology:
- Prevalence: OSA is common, especially in middle-aged and older adults. The risk is higher in men, obese individuals, and those with certain craniofacial features.
- Risk Factors: Obesity, large neck circumference, craniofacial abnormalities, alcohol and sedative use, smoking, and a family history of OSA.
3. Clinical Presentation:
- Symptoms:
- Nocturnal: Loud snoring, witnessed apnoeas, gasping or choking during sleep, frequent awakenings.
- Daytime: Excessive daytime sleepiness (EDS), morning headaches, poor concentration, irritability, and mood disturbances.
- Complications:
- Cardiovascular: Hypertension, atrial fibrillation, heart failure, myocardial infarction, and stroke.
- Metabolic: Increased risk of insulin resistance and type 2 diabetes.
- Psychological: Depression, anxiety, and impaired quality of life.
4. Assessment:
- Epworth Sleepiness Scale (ESS):
- Purpose: Subjective measure of daytime sleepiness; assesses likelihood of dozing off in various situations.
- Scoring:
- 0-9: Normal range.
- 10-15: Mild to moderate sleepiness, indicative of possible sleep disorder.
- ≥16: Severe sleepiness, high likelihood of a sleep disorder such as OSA.
- Lung Function Tests:
- Spirometry: Typically normal in isolated OSA; however, reduced forced expiratory volume (FEV1) and FEV1/FVC ratio may be observed in co-existing obstructive lung disease (e.g., COPD). ~12% of patients with OSA may have a restrictive pattern
- Nocturnal Oximetry: May show intermittent oxygen desaturations corresponding with apnoeic episodes.
5. Diagnosis:
- Sleep Study (Polysomnography): Gold standard diagnostic test, measuring apnoea-hypopnoea index (AHI), oxygen desaturation, sleep stages, and other parameters.
- Home Sleep Apnoea Testing (HSAT): An alternative for moderate to severe OSA in uncomplicated cases.
- Apnoea-Hypopnoea Index (AHI):
- Mild: 5-14 events per hour.
- Moderate: 15-29 events per hour.
- Severe: ≥30 events per hour.
6. Management:
- Lifestyle Modifications:
- Weight Loss: Crucial for reducing OSA severity, particularly in obese patients.
- Positional Therapy: Avoiding supine sleeping position, which can exacerbate OSA.
- Avoidance of Alcohol and Sedatives: These can worsen airway obstruction.
- Continuous Positive Airway Pressure (CPAP):
- First-Line Therapy: Recommended by NICE and BTS for moderate to severe OSA or mild OSA with significant symptoms or cardiovascular comorbidities.
- Mechanism: Delivers continuous air pressure to keep the airway open during sleep, preventing apnoeic episodes.
- Settings:
- Pressure Range: Typically set between 4 and 20 cmH2O; titrated to eliminate apnoeas and hypopnoeas.
- Auto-CPAP (APAP): Automatically adjusts pressure throughout the night based on detected airway resistance.
- BiPAP (Bilevel Positive Airway Pressure): Provides higher inspiratory pressure and lower expiratory pressure; used in patients with CSA or those who have difficulty exhaling against CPAP pressure.
- Duration of Use: CPAP should be used every night for at least 4 hours (ideally the entire sleep duration) to achieve maximum benefit.
- Mandibular Advancement Devices (MADs):
- Indication: For mild to moderate OSA, particularly in those who are intolerant of CPAP.
- Mechanism: Holds the lower jaw and tongue forward, increasing airway space.
- Surgical Interventions:
- Indications: Reserved for patients with significant craniofacial abnormalities or those who fail conservative and CPAP therapies.
- Procedures: Uvulopalatopharyngoplasty (UPPP), maxillomandibular advancement, and other site-specific surgeries.